Advertisement
Timothy Ken and John Lem headshots

Psychedelics and the future of treating substance abuse with John Lem and Timothy Ko

Céline Williams |

Entheon Biomedical CEO Timothy Ko and John Lem, the founder of Lobo Genetics are singular in their mission to research genetic driven approaches to developing personalized tools for use in psychedelic-assisted therapeutic treatments for substance use disorders.

With firsthand knowledge of the shortcomings of the current treatment system, Ko, and Lem, the developer behind a direct-to-consumer platform being used in HaluGen’s Psychedelic Genetics test kit, the two are working together to find the right solutions for patients faster and improve outcomes.


Entrepreneurs are the backbone of Canada’s economy. To support Canada’s businesses, subscribe to our YouTube channel and follow us on FacebookInstagramLinkedIn and Twitter.

Want to stay up-to-date on the latest #entrepreneur podcasts and news? Subscribe to our bi-weekly newsletter

Related Podcasts

Entrepreneurship is more than just dreaming of ways to make money

The Canadian-based biotech company, Mountain Valley MD is changing the accessibility of vaccines to people around the world. With...

Read More

Disrupting Commercial Real Estate with Mike Ward

An accomplished investor, advisor, and board member, Mike Ward has invested in private companies for nearly a decade. Mike...

Read More

Bringing gamification into healthcare with Jim Feng of Phyxable

Dr. Jim Feng is a mission-driven serial entrepreneur located out of Markham, Ontario. In 2009, Dr. Feng founded Form...

Read More

Join Our Newsletter

Subscribe to receive info on our latest news and episodes

Subscribe